Tuesday, November 17, 2020 - Wednesday, November 18, 2020
About the SNO Clinical Trials Course The Society for Neuro-Oncology is pleased to host a 2-day Virtual Clinical Trials Course, being Tuesday and Wednesday, November 17 – 18, 2020 from 9am - 1pm (US Central Time) both days. A series of didactic lectures will be presented by pre-eminent faculty with specific areas of expertise with respect to clinical trial design and conduct and will be open to all interested colleagues. These presentations will also be recorded and available for viewing at the conclusion of the course on the SNO website. Program to be posted shortly.
Format of the course After the overwhelmingly positive feedback from the first course in 2019, the planning committee has expanded the course both to the number of participants as well as the content. From the applications received, a cohort of 36 scholars has been selected to provide a more detailed protocol synopsis that will be shared with mentors that includes a statistician. This group will have the opportunity to receive feedback both before the actual course and at two small group sessions for in-person discussion with the mentors. These small group sessions will be held after the didactic portion on each day of the conference, from 1:30pm - 3:30pm.
Registration There is no fee for this year's course, however, all who wish to view the didactic content must register to do so. Registration information will be posted in the coming weeks.
The Group of Scholars will receive additional information regarding their participation and registration.
Educational Goals Upon completion of this course, participants will have an improved understanding of the practical aspects of therapeutic CNS trials, including:
Understanding the fundamentals of good trial design
Understanding the scientific, statistical, regulatory, logistical and ethical aspects of CNS trials,
Integrating correlative studies in CNS trials,
Mitigating challenges to accrual and overcoming accrual barriers, and
Anticipating the future direction of CNS trials.
The select Group of Scholars will work with mentors and biostatisticians to develop and refine protocol concepts and synopses with the intent for activation at the scholar's respective institutions.
Stephen Bagley, MD, University of Pennsylvania
Susan Chang, MD, University of California, San Francisco